ＪＴＰの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/07/03 | 1,393 | 1,393 | 1,346 | 1,357 | -36 | -2.6% | 49,000 |
| 2025/07/02 | 1,375 | 1,407 | 1,361 | 1,393 | -1 | -0.1% | 49,100 |
| 2025/07/01 | 1,401 | 1,418 | 1,393 | 1,394 | -27 | -1.9% | 45,900 |
| 2025/06/30 | 1,454 | 1,459 | 1,419 | 1,421 | -23 | -1.6% | 50,100 |
| 2025/06/27 | 1,450 | 1,484 | 1,428 | 1,444 | +35 | +2.5% | 79,100 |
| 2025/06/26 | 1,388 | 1,458 | 1,382 | 1,409 | +26 | +1.9% | 133,700 |
| 2025/06/25 | 1,313 | 1,388 | 1,298 | 1,383 | +64 | +4.9% | 118,800 |
| 2025/06/24 | 1,283 | 1,323 | 1,275 | 1,319 | +52 | +4.1% | 54,100 |
| 2025/06/23 | 1,287 | 1,287 | 1,256 | 1,267 | -24 | -1.9% | 47,600 |
| 2025/06/20 | 1,291 | 1,300 | 1,280 | 1,291 | +30 | +2.4% | 42,400 |
| 2025/06/19 | 1,261 | 1,272 | 1,253 | 1,261 | +11 | +0.9% | 29,600 |
| 2025/06/18 | 1,243 | 1,260 | 1,242 | 1,250 | +12 | +1% | 27,700 |
| 2025/06/17 | 1,230 | 1,244 | 1,230 | 1,238 | +13 | +1.1% | 32,200 |
| 2025/06/16 | 1,199 | 1,229 | 1,199 | 1,225 | +38 | +3.2% | 63,400 |
| 2025/06/13 | 1,201 | 1,201 | 1,181 | 1,187 | -15 | -1.2% | 52,900 |
| 2025/06/12 | 1,198 | 1,209 | 1,197 | 1,202 | -1 | -0.1% | 6,400 |
| 2025/06/11 | 1,200 | 1,208 | 1,197 | 1,203 | +3 | +0.3% | 12,600 |
| 2025/06/10 | 1,209 | 1,212 | 1,194 | 1,200 | -1 | -0.1% | 24,500 |
| 2025/06/09 | 1,195 | 1,217 | 1,195 | 1,201 | +19 | +1.6% | 25,600 |
| 2025/06/06 | 1,189 | 1,194 | 1,180 | 1,182 | -12 | -1% | 15,000 |
| 2025/06/05 | 1,191 | 1,208 | 1,191 | 1,194 | -10 | -0.8% | 13,800 |
| 2025/06/04 | 1,207 | 1,213 | 1,200 | 1,204 | -9 | -0.7% | 29,400 |
| 2025/06/03 | 1,199 | 1,214 | 1,191 | 1,213 | +5 | +0.4% | 26,300 |
| 2025/06/02 | 1,180 | 1,208 | 1,178 | 1,208 | +35 | +3% | 51,000 |
| 2025/05/30 | 1,174 | 1,188 | 1,173 | 1,173 | ±0 | ±0% | 26,200 |
| 2025/05/29 | 1,189 | 1,189 | 1,170 | 1,173 | -2 | -0.2% | 29,600 |
| 2025/05/28 | 1,185 | 1,202 | 1,175 | 1,175 | -10 | -0.8% | 50,100 |
| 2025/05/27 | 1,163 | 1,189 | 1,163 | 1,185 | +30 | +2.6% | 38,200 |
| 2025/05/26 | 1,135 | 1,155 | 1,130 | 1,155 | +20 | +1.8% | 39,200 |
| 2025/05/23 | 1,158 | 1,158 | 1,133 | 1,135 | -14 | -1.2% | 15,500 |
| 2025/05/22 | 1,125 | 1,158 | 1,123 | 1,149 | +21 | +1.9% | 30,800 |
| 2025/05/21 | 1,142 | 1,157 | 1,128 | 1,128 | -14 | -1.2% | 27,500 |
| 2025/05/20 | 1,151 | 1,162 | 1,141 | 1,142 | -8 | -0.7% | 23,600 |
| 2025/05/19 | 1,107 | 1,170 | 1,107 | 1,150 | +49 | +4.5% | 80,200 |
| 2025/05/16 | 1,081 | 1,130 | 1,080 | 1,101 | -89 | -7.5% | 143,900 |
| 2025/05/15 | 1,225 | 1,249 | 1,144 | 1,190 | -31 | -2.5% | 142,000 |
| 2025/05/14 | 1,206 | 1,221 | 1,184 | 1,221 | +27 | +2.3% | 39,600 |
| 2025/05/13 | 1,200 | 1,205 | 1,182 | 1,194 | +4 | +0.3% | 16,400 |
| 2025/05/12 | 1,181 | 1,190 | 1,175 | 1,190 | +22 | +1.9% | 19,400 |
| 2025/05/09 | 1,171 | 1,179 | 1,168 | 1,168 | +1 | +0.1% | 10,300 |
| 2025/05/08 | 1,176 | 1,176 | 1,161 | 1,167 | -9 | -0.8% | 12,700 |
| 2025/05/07 | 1,188 | 1,196 | 1,174 | 1,176 | -12 | -1% | 20,800 |
| 2025/05/02 | 1,183 | 1,192 | 1,170 | 1,188 | +13 | +1.1% | 16,600 |
| 2025/05/01 | 1,188 | 1,188 | 1,169 | 1,175 | -9 | -0.8% | 8,900 |
| 2025/04/30 | 1,171 | 1,184 | 1,158 | 1,184 | +14 | +1.2% | 12,700 |
| 2025/04/28 | 1,182 | 1,188 | 1,170 | 1,170 | -1 | -0.1% | 9,900 |
| 2025/04/25 | 1,176 | 1,180 | 1,169 | 1,171 | +6 | +0.5% | 17,900 |
| 2025/04/24 | 1,165 | 1,173 | 1,152 | 1,165 | +5 | +0.4% | 20,000 |
| 2025/04/23 | 1,161 | 1,161 | 1,148 | 1,160 | +15 | +1.3% | 11,100 |
| 2025/04/22 | 1,139 | 1,154 | 1,138 | 1,145 | -5 | -0.4% | 7,700 |
1～
50
件表示中 / 3734件
類似銘柄と比較する
現在ご覧いただいている「ＪＴＰ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＴＰ | 134,700円 | +4.6% | +0.2% | 3.19% | 12.75倍 | 2.09倍 |
|
システム開発・運用が主力。セキュリティや生成ＡＩ活用したＤＸへ展開。人材育成コンサルも |
| ブリーチ | 32,500円 | +16.6% | - | 0.00% | 26.49倍 | 0.89倍 |
|
成果報酬型の集客支援展開。当社が広告費負担するモデルに特徴。広告制作から運用まで内製 |
| 博 展 | 50,600円 | +10.9% | +4.3% | 3.95% | 7.82倍 | 2.36倍 |
|
イベントや展示会、販売促進を支援。リアルとデジタルの融合提案を拡充。配当性向３０％メド |
| リニカル | 32,700円 | +7.3% | - | 4.89% | 49.25倍 | 1.02倍 |
|
新薬の治験支援（ＣＲＯ）専業。がん、中枢神経、免疫系から再生医療等展開。市販後調査強化 |
| セルム | 35,600円 | +27.3% | +7.2% | 4.21% | 12.07倍 | 2.84倍 |
|
大企業の組織づくりや人材育成を支援。グローバル企業顧客向け多言語対応支援領域にも参入 |
市場注目の銘柄
チャート関連のコラム
